ABCD Announcements

	NCEPOD Transition study - Health and Social Care Professional survey Hermione Price, Honorary Secretary, ABCD Tuesday, 18th January 2022 NCEPOD are exploring the process of the transition of young people with complex chronic conditions from child to adult health services. The aim of the study is to explore the barriers and facilitators in the process of the transition of... Read More
	Rowan Hillson Inpatient Safety Award 2022 Professor Ketan Dhatariya (Chair JBDS-IP) Friday, 14th January 2022 Due to the pressure on hospital teams during the COVID pandemic, we postponed the 2021 competition but are now launching a revamped award for 2022 which has been amended to take into account the current COVID situation. We are inviting colleagues to... Read More
	2021 Diabetes & Endocrinology Workforce Census Dr Stella George Wednesday, 12th January 2022 We have now launched the annual census of Consultants in Diabetes and Endocrinology. This is being done on behalf of ABCD, SfE, Diabetes UK and The Royal College of Physicians London who are also project managing this census. There... Read More
	NCEPOD Transition study - young person and parent carer online survey Susannah Rowles, Honorary Secretary, ABCD Tuesday, 21st December 2021 NCEPOD are undertaking a study to look at the process of transition from child to adult health services. As part of this study, they are collecting the views of young people and parent carers on the transition process via an online survey... Read More
	ABCD publishes the results of the Integrated survey about diabetes services Dr Dinesh Nagi, ABCD Ex-Officio Chair Friday, 17th December 2021 Today, 17th December 2021, ABCD publishes the results of the Integrated survey about diabetes services. https://bjd-abcd.com/index.php/bjd/article/view/781 Please find the link to the raw data of this survey below.
	Dapagliflozin (Forxiga): no longer authorised for treatment of type 1 diabetes mellitus Dr Hermione Price, ABCD Committee Monday, 13th December 2021 As of 25th October 2021, dapagliflozin 5mg is no longer authorised for the treatment of people with type 1 diabetes mellitus (T1DM) and should no longer be used in this population . This is based on AstraZeneca’s decision to remove the... Read More
	The YDEF Marjorie Prize Dr Thomas Crabtree Friday, 3rd December 2021 The Young Diabetologist and Endocrinologist Forum committee are very pleased to be able to announce the Marjorie Prize. A little known hero in the discovery of insulin was Marjorie the dog who was the first animal to ever be injected with the drug... Read More
	JBDS enteral feeding forms review - we need your help Professor Ketan Dhatariya (Chair JBDS-IP) Tuesday, 23rd November 2021 We are contacting you on behalf of the Joint British Diabetes Societies (JBDS) for inpatient care group. We are currently undertaking a review of our guideline "Glycaemic management during enteral feeding" and as part of this are reaching out... Read More
	Withdrawing of the licence for the use of dapagloflozin in Type 1 diabetes Dr Susannah Rowles Friday, 19th November 2021 ABCD is keen to ensure that all our members are aware of the withdrawing of the licence for the use of dapagloflozin in Type 1 diabetes . Apologies if you've had this update from multiple sources. We are currently collating feedback on this... Read More
	JBDS needs your help Professor Ketan Dhatariya (Chair JBDS-IP) Tuesday, 16th November 2021 JBDS is updating the ‘Variable rate intravenous insulin infusion (VRIII) for medical inpatients with diabetes’ guideline and we need your help. We need to collect evidence and are asking UK diabetes teams to let us know what they are currently... Read More
	Sanofi Inspired Diabetes Symposium Professor Mike Baxter, Chair of Diabetes Update Friday, 15th October 2021 Join us at the Sanofi Inspired Diabetes Update webinar. An opportunity for a multidisciplinary approach to inform and empower you with knowledge from a diverse range of subjects, impacting on different aspects of diabetes management with... Read More
	Simplifying Insulin Regimens: When, Why, and How to Initiate and Intensify Insulin in Type 2 Diabetes Dipesh Patel, Chair ABCD Thursday, 14th October 2021 Wednesday October 20th 2021, 17:00 – 18:00 BST Panelists David Strain, MBChB MD FRCP (moderator) Roopa Mehta, MBBS, MRCP Dipesh Patel, BSc, MBBS PhD, MRCP Rene Wong, MD, FRCPC, MEd Webinar Overview The third and... Read More
	COncise adVice on Inpatient Diabetes (COVID:Diabetes) Professor Gerry Rayman Thursday, 7th October 2021 Post COVID-19 diabetes discharge pathway - risk stratification and follow up guidance for people being discharged from secondary care after COVID-19 infection
	This is Diabetes Campaign Dr Susannah Rowles, Secretary ABCD Wednesday, 6th October 2021 ABCD is very supportive of Diabetes UK's "This Is Diabetes Campaign" which is launching today, the aim of the campaign is to create a connection to people with diabetes - to let them know that Diabetes UK is there for them and... Read More
	RCP specialty careers showcase, 7th October 2021 Susannah Rowles, Honorary Secretary, ABCD Thursday, 30th September 2021 Embarking on a career in medicine is both exciting and challenging, and a one-stop source of practical information is invaluable. The RCP works closely with all medical specialties and this unique day brings together that community to... Read More
	Three new publications from the ABCD nationwide FreeStyle Libre audit published during September 2021 Dr Bob Ryder (Website Co-ordinator, Clinical Lead, ABCD Nationwide Audits) Tuesday, 28th September 2021 Association of British Clinical Diabetologists (ABCD) is pleased to announce three further publications during September 2021 from its real-world audit of the FreeStyle Libre system (FSL), in people with type 1 diabetes (T1D) who use FSL. In... Read More
	Rowan Hillson Inpatient Safety Award 2021 Professor Ketan Dhatariya (Chair JBDS-IP) Friday, 24th September 2021 We are inviting colleagues to submit entries to this year’s competition which will be: ‘The Rowan Hillson Inpatient Safety Award – The best interventions: Redesigning, rebuilding and maintaining safe inpatient diabetes care during COVID’ This... Read More
	Rowan Hillson Inpatient Safety Award 2021 - Relaunched Professor Ketan Dhatariya (Chair JBDS-IP) Friday, 24th September 2021 We are inviting colleagues to submit entries to this year’s competition which will be: ‘The Rowan Hillson Inpatient Safety Award – The best interventions: Redesigning, rebuilding and maintaining safe inpatient diabetes care during COVID’... Read More
	5th TriCounties Diabetic Foot Symposium Dipesh Patel, Chair ABCD Thursday, 9th September 2021 The biennial 5th #TDFS2021 is back this year with a packed programme and a multidisciplinary faculty of leading UK voices in Diabetic Foot Care. Hot topics covered include: The role of AI and Smart Technology in the Diabetic Foot... Read More
	Dr Bob Ryder receives Lifetime Achievement Award Dr Dipesh Patel, Chair ABCD Tuesday, 31st August 2021 ABCD would like to congratulate Dr Bob Ryder on his recent Lifetime Achievement Award. Dr Ryder received this award during the 7th International Diabetes and Endocrine Conference for services to MRCP and UK Audits via ABCD. I am sure you... Read More